Online Program

Evidence-based educational outreach to clinicians to counter pharmaceutical marketing (“academic detailing”)

Tuesday, November 5, 2013 : 11:00 a.m. - 11:15 a.m.

Jerry Avorn, MD, Division of Pharmaco-epidemiology and Pharmaco-economics, Harvard Medical School and Brigham and Women's Hospital, Boston, MA

Learning Areas:

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: Jerry Avorn, MD, is Professor of Medicine at Harvard Medical School and Chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital. His research focuses on the benefits, risks, and costs of medications, and strategies to improve the use and outcomes of prescription drugs. Dr. Avorn is the author or co-author of over 450 papers, and of “Powerful Medicines: The Benefits, Risks, and Costs of Prescription Drugs,” now in its 11th printing.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.